These data suggest that the concentration-dependent bidirectional regulatory effect of ANP on gastric cancer cell proliferation is driven by KCNQ1-mediated changes in potassium channel activity, suggesting that KCNQ1 shows potential as an effective therapeutic target in the treatment of gastric cancer. This evidence concerns the gene KCNQ1 and gastric cancer.